The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Open accessAbstract
Colorectal cancer (CRC) is the most common cancer of the digestive system with high mortality and morbidity rates. Gut microbiota is found in the intestines, especially the colorectum, and has structured crosstalk interactions with the host that affect several physiological processes. The gut microbiota include CRC‐promoting bacterial species, such as Fusobacterium nucleatum, Escherichia coli, and Bacteroides fragilis, and CRC‐protecting bacterial species, such as Clostridium butyricum, Streptococcus thermophilus, and Lacticaseibacillus paracasei, which along with other microorganisms, such as viruses and fungi, play critical roles in the development of CRC. Different bacterial features are identified in patients with early‐onset CRC, combined with different patterns between fecal and intratumoral microbiota. The gut microbiota may be beneficial in the diagnosis and treatment of CRC; some bacteria may serve as biomarkers while others as regulators of chemotherapy and immunotherapy. Furthermore, metabolites produced by the gut microbiota play essential roles in the crosstalk with CRC cells. Harmful metabolites include some primary bile acids and short‐chain fatty acids, whereas others, including ursodeoxycholic acid and butyrate, are beneficial and impede tumor development and progression. This review focuses on the gut microbiota and its metabolites, and their potential roles in the development, diagnosis, and treatment of CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–240 of 240
Butyrate ameliorated-NLRC3 protects the intestinal barrier in a GPR43-dependent manner
Cheng, D., Xu, J., Li, J., Wang, S., Wu, T., Chen, Q., & Yu, T. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.04.018 · Cited by 72
Epigenetic Changes Induced by Bacteroides fragilis Toxin
Allen, J., Hao, S., Sears, C. L., & Timp, W. (2019) · Infection and Immunity · doi:10.1128/iai.00447-18 · Cited by 72
Xue, M., Liang, H. W., Ji, X., Zhou, Z., Liu, Y., Sun, T., & Zhang, L. (2020) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2020.108396 · Cited by 70
Tumour-associated and non-tumour-associated microbiota in colorectal cancer
Al-Hassi, H. O., Ng, O., & Brookes, M. (2017) · Gut · doi:10.1136/gutjnl-2017-314219 · Cited by 70
Ge, L., Qi, J., Shao, B., Ruan, Z., Ren, Y., Sui, S., Wu, X., Sun, X., Liu, S., Li, S., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2013764 · Cited by 69
Shi, Y., Meng, L., Zhang, C., Zhang, F., & Fang, Y. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126921 · Cited by 68
Preoperative Serum TMAO Level is a New Prognostic Marker for Colorectal Cancer
Liu, X., Liu, H., Yuan, C., Zhang, Y., Wang, W., Hu, S., Liu, L., & Wang, Y. (2017) · Biomarkers in Medicine · doi:10.2217/bmm-2016-0262 · Cited by 67
Self-citationWang, L., Gao, M., Kang, G., & Huang, H. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.798038 · Cited by 66
Taylor, J. C., Gao, X., Xu, J., Holder, M., Petrosino, J. F., Kumar, R., Liu, W., Höök, M., Mackenzie, C., Hillhouse, A., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009182 · Cited by 64
RNA virus receptor Rig-I monitors gut microbiota and inhibits colitis-associated colorectal cancer
Zhu, H., Xu, W., Hu, Z., Zhang, H., Shen, Y., Lu, S., Wei, C., & Wang, Z. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0471-3 · Cited by 62
Baxter, N. T., Koumpouras, C. C., Rogers, M. A. M., Ruffin, M. T., & Schloss, P. D. (2016) · Microbiome · doi:10.1186/s40168-016-0205-y · Cited by 59
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
Ganesan, K., Guo, S., Fayyaz, S., Zhang, G., & Xu, B. (2019) · Cancers · doi:10.3390/cancers11101592 · Cited by 59
Propionic acid bacteria in the food industry: An update on essential traits and detection methods
Bücher, C., Burtscher, J., & Domig, K. J. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12804 · Cited by 59
Zuo, L., Lu, M., Zhou, Q., Wei, W., & Wang, Y. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.10.028 · Cited by 57
Shakour, Z. T. A., Shehab, N. G., Gomaa, A. S., Wessjohann, L. A., & Farag, M. A. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107784 · Cited by 57
Kong, F., Fang, C., Zhang, Y., Duan, L., Du, D., Xu, G., Li, X., Li, H., Yin, Y., Xu, H., et al. (2022) · Advanced Science · doi:10.1002/advs.202105523 · Cited by 57
Self-citationChondrou, P., Karapetsas, A., Kiousi, D. E., Tsela, D., Tiptiri-Kourpeti, A., Anestopoulos, I., Kotsianidis, Ι., Bezirtzoglou, E., Pappa, A., & Galanis, Α. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0183 · Cited by 56
Zhang, Y., Weng, Y., Gan, H., Zhao, X., & Zhi, F. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.136 · Cited by 56
Self-citationButt, J., Romero‐Hernández, B., Pérez‐Gómez, B., Willhauck‐Fleckenstein, M., Holzinger, D., Martín, V., Moreno, V. R., Linares, C., Dierssen‐Sotos, T., Barricarte, A., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29914 · Cited by 55
Nozari, S., Faridvand, Y., Etesami, S. A., Beiki, M. A. K., Mazrakhondi, S. A. M., & Abdolalizadeh, J. (2019) · Letters in Applied Microbiology · doi:10.1111/lam.13198 · Cited by 54
Monocarboxylate transporter 1 (MCT1) mediates transport of short‐chain fatty acids in bovine caecum
Kirat, D., & Kato, S. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.033837 · Cited by 53
Yao, Y., Li, X., Xu, B., Luo, L., Guo, Q., Wang, X., Sun, L., Zhang, Z., & Li, P. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00890-8 · Cited by 50
Self-citationHattori, N., Niwa, T., Ishida, T., KOBAYASHI, K., Imai, T., Mori, A., Kimura, K., Mori, T., Asami, Y., & Ushijima, T. (2018) · Cancer Science · doi:10.1111/cas.13880 · Cited by 46
Gao, R. Y., Shearn, C. T., Orlicky, D. J., Battista, K. D., Alexeev, E. E., Cartwright, I. M., Lanis, J. M., Kostelecky, R. E., Ju, C., Colgan, S. P., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00347-6 · Cited by 42
Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay
Zhang, Y., Wu, Q., Xu, L., Wang, H., Liu, X., Li, S., Hu, T., Liu, Y., Peng, Q., Chen, Z., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01076-8 · Cited by 42
Self-citationLi, J., Zhou, X., Liu, X., Ren, J., Wang, J., Wang, W., Zheng, Y., Shi, X., Sun, T., Li, Z., et al. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.301804 · Cited by 41
Self-citationExpanding the Colorectal Cancer Biomarkers Based on the Human Gut Phageome
Shen, S., Huo, D., Ma, C., Jiang, S., & Zhang, J. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00090-21 · Cited by 37
Shah, M. S., DeSantis, T. Z., Yamal, J., Weir, T. L., Ryan, E. P., Cope, J. L., & Hollister, E. B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207002 · Cited by 34
Mutignani, M., Penagini, R., Gargari, G., Guglielmetti, S., Cintolo, M., Airoldi, A., Leone, P., Carnevali, P., Ciafardini, C., Petrocelli, G., et al. (2021) · Cancers · doi:10.3390/cancers13246363 · Cited by 34
Duarte, V. D. S., Cruz, B. C. D. S., Tarrah, A., Dias, R. S., Moreira, L. D. P. D., Lemos, W. J. F., Silva, L. C. F., Santana, G. R., de Oliveira, L. L., Pelúzio, M. D. C. G., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8121994 · Cited by 31
Chen, Y., Li, J., Menon, R., Jayaraman, A., Lee, K., Huang, Y., Dashwood, W. M., Zhang, K., Sun, D., & Dashwood, R. H. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1972756 · Cited by 31
Hu, P., Song, W., Shan, Y., Du, M., Huang, M., Song, C., & Zhang, L. (2015) · Food & Function · doi:10.1039/c5fo00248f · Cited by 27
Qu, R., Ma, Y., Tao, L., Bao, X., Zhou, X., Wang, B., Li, F., Lu, S., Tuo, L., Zhan, S., et al. (2021) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2021.04.07 · Cited by 25
Self-citationBacteria-related changes in host DNA methylation and the risk for CRC
Sobhani, I., Rotkopf, H., & Khazaie, K. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1800898 · Cited by 24
Mapping the colorectal tumor microbiota
Murphy, C., Barrett, M., Pellanda, P., Killeen, S., McCourt, M., Andrews, E., Riordain, M. O., Shanahan, F., & O’Toole, P. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1920657 · Cited by 24
Arvind, P., Papavassiliou, E. D., Tsioulias, G. J., Duceman, B. W., Lovelace, C. I. P., Wang, G., Staiano‐Coico, L., & Rigas, B. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90168-6 · Cited by 22
Chen, J., & Vitetta, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113655118 · Cited by 22
Hattori, K., Sakata‐Yanagimoto, M., Kusakabe, M., Nanmoku, T., Suehara, Y., Matsuoka, R., Noguchi, M., Yokoyama, Y., Kato, T., Kurita, N., et al. (2018) · Cancer Science · doi:10.1111/cas.13848 · Cited by 21
Zhang, M., Lai, Y., Krupalnik, V., Guo, P., Guo, X., Zhou, J., Xu, Y., Yu, Z., Liu, L., Jiang, A., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1593 · Cited by 17
NOD2 prevents emergence of disease-predisposing microbiota
Sécher, T., Normand, S., & Chamaillard, M. (2013) · Gut Microbes · doi:10.4161/gmic.25275 · Cited by 11
Cited by
The Role of Short Chain Fatty Acids in Inflammation and Body Health
Du, Y., He, C., An, Y., Huang, Y., Zhang, H., Fu, W., Wang, M., Shan, Z., Xie, J., Yang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137379 · Cited by 384
Self-citationA comprehensive review of probiotics and human health-current prospective and applications
Sarita, B., Samadhan, D., Hassan, M. Z., & Kovaleva, E. G. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1487641 · Cited by 250
Zhu, R., Gu, S., Tao, Y., & Zhang, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-02686-x · Cited by 8
Self-citation
Metadata
- Authors
- Qu, R., Zhang, Y., Ma, Y., Zhou, X., Sun, L., Jiang, C., Zhang, Z., & Fu, W.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2023-06
- Volume
- 10
- Issue
- 23
- Pages
- e2205563-e2205563
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W4379094084
- Cited by
- 297
- References
- 240
- FWCI
- 22.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.